{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:10:11Z","timestamp":1788930611622,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03351-1","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:07:56Z","timestamp":1786086476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid peroxidation in cancer: a double-edged sword shaping progression and therapy"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-4251","authenticated-orcid":false,"given":"Kieran V.","family":"Allowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"3","key":"3351_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","volume":"9","author":"H Nagai","year":"2017","unstructured":"Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448\u201351.","journal-title":"J Thorac Dis"},{"issue":"7","key":"3351_CR2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912\u20139.","journal-title":"Int J Radiat Biol"},{"issue":"5","key":"3351_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"3351_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040580","author":"L Zhu","year":"2022","unstructured":"Zhu L, Zhu X, Wu Y. Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12040580.","journal-title":"Biomolecules"},{"key":"3351_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110735","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, et al. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019. https:\/\/doi.org\/10.3390\/biom9110735.","journal-title":"Biomolecules"},{"key":"3351_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2017.03.025","volume":"397","author":"J O\u2019Malley","year":"2017","unstructured":"O\u2019Malley J, Kumar R, Kuzmin AN, Pliss A, Yadav N, Balachandar S, Wang J, Attwood K, Prasad PN, Chandra D. Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer. Cancer Lett. 2017;397:52\u201360.","journal-title":"Cancer Lett"},{"issue":"5","key":"3351_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","volume":"26","author":"N Zhang","year":"2019","unstructured":"Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, Sun M, Chen B, Zhao W, Wang L, Wang H, Moran MS, Haffty BG, Yang Q. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1\/2. Cell Death Differ. 2019;26(5):843\u201359.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3351_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","volume":"16","author":"X Luo","year":"2017","unstructured":"Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.","journal-title":"Mol Cancer"},{"key":"3351_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2015.02.023","volume":"83","author":"F Gueraud","year":"2015","unstructured":"Gueraud F, Tache S, Steghens JP, Milkovic L, Borovic-Sunjic S, Zarkovic N, Gaultier E, Naud N, Helies-Toussaint C, Pierre F, Priymenko N. Dietary polyunsaturated fatty acids and heme iron induce oxidative stress biomarkers and a cancer promoting environment in the colon of rats. Free Radic Biol Med. 2015;83:192\u2013200.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"3351_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.21873\/invivo.12764","volume":"36","author":"M Eskelinen","year":"2022","unstructured":"Eskelinen M, Saimanen I, Koskela R, Holopainen A, Selander T, Eskelinen M. Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Etaydroxynonenal (4-HNE) in Benign and Cancer Patients. Vivo. 2022;36(2):773\u20139.","journal-title":"Vivo"},{"issue":"1","key":"3351_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12885-023-10509-x","volume":"23","author":"M Merino Salvador","year":"2023","unstructured":"Merino Salvador M, Fernandez LP, Moreno-Rubio J, Colmenarejo G, Casado E, Ramirez de Molina A, et al. Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer. BMC Cancer. 2023;23(1):36.","journal-title":"BMC Cancer"},{"key":"3351_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101828","volume":"39","author":"Q Peng","year":"2024","unstructured":"Peng Q, Tao J, Xu Y, Shen Y, Wang Y, Jiao Y, et al. Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. Transl Oncol. 2024;39:101828.","journal-title":"Transl Oncol"},{"issue":"1","key":"3351_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2017.11.012","volume":"104","author":"CT Shearn","year":"2018","unstructured":"Shearn CT, Orlicky DJ, Petersen DR. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis\/Inflammatory Bowel Disease. Exp Mol Pathol. 2018;104(1):1\u20138.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"3351_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41420-023-01613-9","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang X, Hou L, Guo Z, Wang G, Xu J, Zheng Z, Sun K, Guo F. Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis. Cell Death Discov. 2023;9(1):320.","journal-title":"Cell Death Discov"},{"key":"3351_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mcn.2019.06.004","volume":"98","author":"G Acosta","year":"2019","unstructured":"Acosta G, Race N, Herr S, Fernandez J, Tang J, Rogers E, et al. Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration. Mol Cell Neurosci. 2019;98:140\u201354.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"3351_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ars.2019.7955","volume":"34","author":"E Gianazza","year":"2021","unstructured":"Gianazza E, Brioschi M, Martinez Fernandez A, Casalnuovo F, Altomare A, Aldini G, et al. Lipid peroxidation in atherosclerotic cardiovascular diseases. Antioxid Redox Signal. 2021;34(1):49\u201398.","journal-title":"Antioxid Redox Signal"},{"key":"3351_CR17","first-page":"200143","volume":"14","author":"R Salekeen","year":"2022","unstructured":"Salekeen R, Haider AN, Akhter F, Billah MM, Islam ME. Didarul Islam, Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies. Int J Cardiol Cardiovasc Risk Prev. 2022;14:200143.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"3351_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11102071","author":"SC Shabalala","year":"2022","unstructured":"Shabalala SC, Johnson R, Basson AK, Ziqubu K, Hlengwa N, Mthembu SXH, et al. Detrimental effects of lipid peroxidation in type 2 diabetes: exploring the neutralizing influence of antioxidants. Antioxidants (Basel). 2022. https:\/\/doi.org\/10.3390\/antiox11102071.","journal-title":"Antioxidants (Basel)"},{"key":"3351_CR19","doi-asserted-by":"publisher","DOI":"10.2174\/011570159X342720241014164650","author":"K Allowitz","year":"2024","unstructured":"Allowitz K, Taylor J, Harames K, Yoo J, Baloch O, Ramana KV. Oxidative stress-mediated lipid peroxidation-derived lipid aldehydes in the pathophysiology of neurodegenerative diseases. Curr Neuropharmacol. 2024. https:\/\/doi.org\/10.2174\/011570159X342720241014164650.","journal-title":"Curr Neuropharmacol"},{"key":"3351_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","author":"A Ayala","year":"2014","unstructured":"Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014. https:\/\/doi.org\/10.1155\/2014\/360438.","journal-title":"Oxid Med Cell Longev"},{"key":"3351_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1322746","volume":"14","author":"L Xiao","year":"2023","unstructured":"Xiao L, Xian M, Zhang C, Guo Q, Yi Q. Lipid peroxidation of immune cells in cancer. Front Immunol. 2023;14:1322746.","journal-title":"Front Immunol"},{"key":"3351_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1397352","volume":"15","author":"HK Krishnamurthy","year":"2024","unstructured":"Krishnamurthy HK, Rajavelu I, Pereira M, Jayaraman V, Krishna K, Wang T, et al. Inside the genome: understanding genetic influences on oxidative stress. Front Genet. 2024;15:1397352.","journal-title":"Front Genet"},{"key":"3351_CR23","first-page":"p2233906","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao T, Li J, Xia M, Li Y, Wang X, Liu C, Zheng T, Chen R, Kan D, Xie Y, Song J, Feng Y, Yu T, Sun P. Oxidative Stress and 4-hydroxy-2-nonenal (4-HNE): Implications in the Pathogenesis and Treatment of Aging-related Diseases. J Immunol Res. 2022;2022:p2233906.","journal-title":"J Immunol Res"},{"key":"3351_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","volume":"4","author":"H Zhong","year":"2015","unstructured":"Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 2015;4:193\u20139.","journal-title":"Redox Biol"},{"key":"3351_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8030072","author":"F Ito","year":"2019","unstructured":"Ito F, Sono Y, Ito T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants. 2019. https:\/\/doi.org\/10.3390\/antiox8030072.","journal-title":"Antioxidants"},{"issue":"3","key":"3351_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"3351_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.665591","volume":"9","author":"L Lei","year":"2021","unstructured":"Lei L, Zhang J, Decker EA, Zhang G. Roles of lipid peroxidation-derived electrophiles in pathogenesis of colonic inflammation and colon cancer. Front Cell Dev Biol. 2021;9:665591.","journal-title":"Front Cell Dev Biol"},{"key":"3351_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.772101","volume":"12","author":"M Lucafo","year":"2021","unstructured":"Lucafo M, Curci D, Franzin M, Decorti G, Stocco G. Inflammatory bowel disease and risk of colorectal cancer: an overview from pathophysiology to pharmacological prevention. Front Pharmacol. 2021;12:772101.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3351_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/tx100323m","volume":"24","author":"CE McGrath","year":"2011","unstructured":"McGrath CE, Tallman KA, Porter NA, Marnett LJ. Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxynonenal and 4-oxononenal analogues. Chem Res Toxicol. 2011;24(3):357\u201370.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"3351_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3325\/cmj.2023.64.29","volume":"64","author":"PY Ng","year":"2023","unstructured":"Ng PY, Nafi SNM, Jalil NAC, Kueh YC, Lee YY, Zin AAM. Immunohistochemical expression of apolipoprotein B and 4-hydroxynonenal proteins in colorectal carcinoma patients: a retrospective study. Croat Med J. 2023;64(1):29\u201336.","journal-title":"Croat Med J"},{"key":"3351_CR31","doi-asserted-by":"publisher","first-page":"102662","DOI":"10.1016\/j.redox.2023.102662","volume":"62","author":"D Acevedo-Leon","year":"2023","unstructured":"Acevedo-Leon D, Gomez-Abril SA, Sanz-Garcia P, Estan-Capell N, Banuls C, Saez G. The role of oxidative stress, tumor and inflammatory markers in colorectal cancer patients: A one-year follow-up study. Redox Biol. 2023;62:102662.","journal-title":"Redox Biol"},{"key":"3351_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101880","volume":"42","author":"L Lei","year":"2021","unstructured":"Lei L, Yang J, Zhang J, Zhang G. The lipid peroxidation product EKODE exacerbates colonic inflammation and colon tumorigenesis. Redox Biol. 2021;42:101880.","journal-title":"Redox Biol"},{"issue":"4\u20135","key":"3351_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0098-2997(03)00022-0","volume":"24","author":"D Zanetti","year":"2003","unstructured":"Zanetti D, Poli G, Vizio B, Zingaro B, Chiarpotto E, Biasi F. 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer. Mol Aspects Med. 2003;24(4\u20135):273\u201380.","journal-title":"Mol Aspects Med"},{"key":"3351_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194663","author":"MV Guryleva","year":"2022","unstructured":"Guryleva MV, Penzar DD, Chistyakov DV, Mironov AA, Favorov AV, Sergeeva MG. Investigation of the role of PUFA metabolism in breast cancer using a rank-based random forest algorithm. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194663.","journal-title":"Cancers (Basel)"},{"issue":"23","key":"3351_CR35","doi-asserted-by":"publisher","first-page":"10151","DOI":"10.7314\/APJCP.2014.15.23.10151","volume":"15","author":"YP Li","year":"2014","unstructured":"Li YP, Tian FG, Shi PC, Guo LY, Wu HM, Chen RQ, Xue JM. 4-Hydroxynonenal promotes growth and angiogenesis of breast cancer cells through HIF-1alpha stabilization. Asian Pac J Cancer Prev. 2014;15(23):10151\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"3351_CR36","first-page":"640","volume":"49","author":"CP Rajneesh","year":"2008","unstructured":"Rajneesh CP, Manimaran A, Sasikala KR, Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singap Med J. 2008;49(8):640\u20133.","journal-title":"Singap Med J"},{"issue":"12","key":"3351_CR37","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.31557\/APJCP.2018.19.12.3511","volume":"19","author":"P Kangari","year":"2018","unstructured":"Kangari P, Zarnoosheh Farahany T, Golchin A, Ebadollahzadeh S, Salmaninejad A, Mahboob SA, et al. Enzymatic antioxidant and lipid peroxidation evaluation in the newly diagnosed breast cancer patients in Iran. Asian Pac J Cancer Prev. 2018;19(12):3511\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"3351_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1055\/s-0034-1372580","volume":"64","author":"C Wang","year":"2014","unstructured":"Wang C, Yu J, Wang H, Zhang J, Wu N. Lipid peroxidation and altered anti-oxidant status in breast adenocarcinoma patients. Drug Res (Stuttg). 2014;64(12):690\u20132.","journal-title":"Drug Res (Stuttg)"},{"key":"3351_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18632\/oncoscience.550","volume":"9","author":"ST de Oliveira","year":"2022","unstructured":"de Oliveira ST, Bessani MP, Scandolara TB, Silva JC, Kawassaki ACB, Fagotti PAF, Maito VT, de Souza JA, Rech D, Panis C. Systemic lipid peroxidation profile from patients with breast cancer changes according to the lymph nodal metastasis status. Oncoscience. 2022;9:1\u201310.","journal-title":"Oncoscience"},{"key":"3351_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091732","author":"YS Seo","year":"2023","unstructured":"Seo YS, Park JM, Kim JH, Lee MY. Cigarette smoke-induced reactive oxygen species formation: a concise review. Antioxidants (Basel). 2023. https:\/\/doi.org\/10.3390\/antiox12091732.","journal-title":"Antioxidants (Basel)"},{"key":"3351_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031770","author":"C Cipollina","year":"2022","unstructured":"Cipollina C, Bruno A, Fasola S, Cristaldi M, Patella B, Inguanta R, et al. Cellular and molecular signatures of oxidative stress in bronchial epithelial cell models injured by cigarette smoke extract. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031770.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3351_CR42","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/mnfr.201100148","volume":"55","author":"MS Tang","year":"2011","unstructured":"Tang MS, Wang HT, Hu Y, Chen WS, Akao M, Feng Z, et al. Acrolein induced DNA damage, mutagenicity and effect on DNA repair. Mol Nutr Food Res. 2011;55(9):1291\u2013300.","journal-title":"Mol Nutr Food Res"},{"issue":"42","key":"3351_CR43","doi-asserted-by":"publisher","first-page":"15404","DOI":"10.1073\/pnas.0607031103","volume":"103","author":"Z Feng","year":"2006","unstructured":"Feng Z, Hu W, Hu Y, Tang MS. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci U S A. 2006;103(42):15404\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"3351_CR44","doi-asserted-by":"publisher","first-page":"33226","DOI":"10.18632\/oncotarget.5429","volume":"6","author":"HW Lee","year":"2015","unstructured":"Lee HW, Wang HT, Weng MW, Chin C, Huang W, Lepor H, et al. Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation. Oncotarget. 2015;6(32):33226\u201336.","journal-title":"Oncotarget"},{"issue":"9","key":"3351_CR45","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.3390\/ijerph10093886","volume":"10","author":"A Valavanidis","year":"2013","unstructured":"Valavanidis A, Vlachogianni T, Fiotakis K, Loridas S. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Public Health. 2013;10(9):3886\u2013907.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"3351_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/ijms17030322","volume":"17","author":"RA Pietrofesa","year":"2016","unstructured":"Pietrofesa RA, Velalopoulou A, Albelda SM, Christofidou-Solomidou M. Asbestos Induces Oxidative Stress and Activation of Nrf2 Signaling in Murine Macrophages: Chemopreventive Role of the Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605). Int J Mol Sci. 2016;17(3):322.","journal-title":"Int J Mol Sci"},{"key":"3351_CR47","first-page":"210","volume":"9","author":"A Gegotek","year":"2016","unstructured":"Gegotek A, Niklinski J, Zarkovic N, Zarkovic K, Waeg G, Luczaj W, Charkiewicz R, Skrzydlewska E. Lipid mediators involved oxidative stress Antioxid Def Hum lung cancer cells Redox Biol. 2016;9:210\u20139.","journal-title":"Lipid mediators involved oxidative stress Antioxid Def Hum lung cancer cells Redox Biol"},{"issue":"Suppl 1","key":"3351_CR48","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.freeradbiomed.2014.10.761","volume":"75","author":"A Gegotek","year":"2014","unstructured":"Gegotek A, Niklinski J, Charkiewicz R, Bielawska K, Kozlowski M, Skrzydlewska E. Relationships between level of lipid peroxidation products and expression of Nrf2 and its activators\/ inhibitors in non-small cell lung cancer tissue. Free Radic Biol Med. 2014;75(Suppl 1):S31.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3351_CR49","doi-asserted-by":"publisher","first-page":"e0215246","DOI":"10.1371\/journal.pone.0215246","volume":"14","author":"K Zablocka-Slowinska","year":"2019","unstructured":"Zablocka-Slowinska K, Placzkowska S, Skorska K, Prescha A, Pawelczyk K, Porebska I, Kosacka M, Grajeta H. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism. PLoS ONE. 2019;14(4):e0215246.","journal-title":"PLoS ONE"},{"key":"3351_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12060561","author":"SR Sutaria","year":"2022","unstructured":"Sutaria SR, Gori SS, Morris JD, Xie Z, Fu XA, Nantz MH. Lipid peroxidation produces a diverse mixture of saturated and unsaturated aldehydes in exhaled breath that can serve as biomarkers of lung cancer-a review. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12060561.","journal-title":"Metabolites"},{"key":"3351_CR51","doi-asserted-by":"crossref","unstructured":"Borovic Sunjic S, Jaganjac M, Vlainic J, Halasz M, Zarkovic N. Lipid Peroxidation-Related Redox Signaling in Osteosarcoma. Int J Mol Sci, 2024. 25(8):4559","DOI":"10.3390\/ijms25084559"},{"issue":"3","key":"3351_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/10815589221145043","volume":"71","author":"A Rafeeinia","year":"2023","unstructured":"Rafeeinia A, Asadikaram G, Karimi Darabi M, Abolhassani M, Moazed V, Abbasi-Jorjandi M. Organochlorine pesticides, oxidative stress biomarkers, and leukemia: a case-control study. J Investig Med. 2023;71(3):295\u2013306.","journal-title":"J Investig Med"},{"issue":"1","key":"3351_CR53","first-page":"55","volume":"20","author":"D Terzioglu","year":"2016","unstructured":"Terzioglu D, Teksoz S, Arikan AE, Uslu E, Yilmaz E, Eren B. Relationship of hemoxygenase-1 and prolidase enzyme activity with oxidative stress in papillary thyroid cancer. Hippokratia. 2016;20(1):55\u20139.","journal-title":"Hippokratia"},{"issue":"3","key":"3351_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100748","volume":"13","author":"W Wu","year":"2020","unstructured":"Wu W, Wu Y, Mayer K, von Rosenstiel C, Schecker J, Baur S, et al. Lipid peroxidation plays an important role in chemotherapeutic effects of temozolomide and the development of therapy resistance in human glioblastoma. Transl Oncol. 2020;13(3):100748.","journal-title":"Transl Oncol"},{"issue":"2","key":"3351_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52(2):192\u2013203.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3351_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","volume":"4","author":"S Feng","year":"2023","unstructured":"Feng S, Tang D, Wang Y, Li X, Bao H, Tang C, Dong X, Li X, Yang Q, Yan Y, Yin Z, Shang T, Zheng K, Huang X, Wei Z, Wang K, Qi S. The mechanism of ferroptosis and its related diseases. Mol Biomed. 2023;4(1):33.","journal-title":"Mol Biomed"},{"issue":"5","key":"3351_CR57","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"6","key":"3351_CR58","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"key":"3351_CR59","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.redox.2017.04.013","volume":"12","author":"L Milkovic","year":"2017","unstructured":"Milkovic L, Zarkovic N, Saso L. Controversy about pharmacological modulation of Nrf2 for cancer therapy. Redox Biol. 2017;12:727\u201332.","journal-title":"Redox Biol"},{"issue":"5\u20136","key":"3351_CR60","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.phrs.2008.09.003","volume":"58","author":"A Lau","year":"2008","unstructured":"Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res. 2008;58(5\u20136):262\u201370.","journal-title":"Pharmacol Res"},{"key":"3351_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2746457","volume":"2016","author":"J Kim","year":"2016","unstructured":"Kim J, Keum YS. NRF2, a key regulator of antioxidants with two faces towards cancer. Oxid Med Cell Longev. 2016;2016:2746457.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"3351_CR62","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-19-0070","volume":"79","author":"S Tao","year":"2019","unstructured":"Tao S, Wang S, Moghaddam SJ, Ooi A, Chapman E, Wong PK, Zhang DD. Correction: Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2. Cancer Res. 2019;79(5):1015.","journal-title":"Cancer Res"},{"issue":"2","key":"3351_CR63","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s11033-022-08126-1","volume":"50","author":"M Poornashree","year":"2023","unstructured":"Poornashree M, Kumar H, Ajmeer R, Jain R, Jain V. Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions. Mol Biol Rep. 2023;50(2):1871\u201383.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3351_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41490-x","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yang W, Yang L, Wang T, Li C, Yu J, et al. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis. Sci Rep. 2023;13(1):14359.","journal-title":"Sci Rep"},{"issue":"2","key":"3351_CR65","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00280-011-1722-9","volume":"69","author":"X Ma","year":"2012","unstructured":"Ma X, Zhang J, Liu S, Huang Y, Chen B, Wang D. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer. Cancer Chemother Pharmacol. 2012;69(2):485\u201394.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3351_CR66","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"JL Roh","year":"2017","unstructured":"Roh JL, Kim EH, Jang H, Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol. 2017;11:254\u201362.","journal-title":"Redox Biol"},{"key":"3351_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.661157","volume":"11","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhao S, Meng F, Wang H, Sun L, Li G, et al. Nrf2 down-regulation by camptothecin favors inhibiting invasion, metastasis and angiogenesis in hepatocellular carcinoma. Front Oncol. 2021;11:661157.","journal-title":"Front Oncol"},{"issue":"5","key":"3351_CR68","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.18632\/oncotarget.13825","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Su L, Ye Q, Zhang S, Kung H, Jiang F, et al. Discovery of a novel Nrf2 inhibitor that induces apoptosis of human acute myeloid leukemia cells. Oncotarget. 2017;8(5):7625\u201336.","journal-title":"Oncotarget"},{"issue":"1","key":"3351_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40364-020-00242-z","volume":"8","author":"NM Kaweme","year":"2020","unstructured":"Kaweme NM, Zhou S, Changwe GJ, Zhou F. The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications. Biomark Res. 2020;8(1):63.","journal-title":"Biomark Res"},{"key":"3351_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111755","author":"AA Zimta","year":"2019","unstructured":"Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, et al. The role of Nrf2 activity in cancer development and progression. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11111755.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3351_CR71","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.1014275108","volume":"108","author":"D Ren","year":"2011","unstructured":"Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci U S A. 2011;108(4):1433\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3351_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1269581","volume":"14","author":"S Afzal","year":"2023","unstructured":"Afzal S, Abdul Manap AS, Attiq A, Albokhadaim I, Kandeel M, Alhojaily SM. From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Front Pharmacol. 2023;14:1269581.","journal-title":"Front Pharmacol"},{"key":"3351_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1680-4","volume":"15","author":"E Jablonska","year":"2015","unstructured":"Jablonska E, Gromadzinska J, Peplonska B, Fendler W, Reszka E, Krol MB, et al. Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1. BMC Cancer. 2015;15:657.","journal-title":"BMC Cancer"},{"key":"3351_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00213","volume":"8","author":"S Liu","year":"2020","unstructured":"Liu S, Li B, Xu J, Hu S, Zhan N, Wang H, et al. SOD1 promotes cell proliferation and metastasis in non-small cell lung cancer via an miR-409-3p\/SOD1\/SETDB1 epigenetic regulatory feedforward loop. Front Cell Dev Biol. 2020;8:213.","journal-title":"Front Cell Dev Biol"},{"key":"3351_CR75","doi-asserted-by":"publisher","first-page":"p2901840","DOI":"10.1155\/2019\/2901840","volume":"2019","author":"M Zalewska-Ziob","year":"2019","unstructured":"Zalewska-Ziob M, Adamek B, Kasperczyk J, Romuk E, Hudziec E, Chwalinska E, Dobija-Kubica K, Rogozinski P, Brulinski K. Activity of Antioxidant Enzymes in the Tumor and Adjacent Noncancerous Tissues of Non-Small-Cell Lung Cancer. Oxid Med Cell Longev. 2019;2019:p2901840.","journal-title":"Oxid Med Cell Longev"},{"key":"3351_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105698","volume":"120","author":"A Gaya-Bover","year":"2020","unstructured":"Gaya-Bover A, Hernandez-Lopez R, Alorda-Clara M, Ibarra de la Rosa JM, Falco E, Fernandez T, et al. Antioxidant enzymes change in different non-metastatic stages in tumoral and peritumoral tissues of colorectal cancer. Int J Biochem Cell Biol. 2020;120:105698.","journal-title":"Int J Biochem Cell Biol"},{"key":"3351_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063164","author":"W Udomsak","year":"2024","unstructured":"Udomsak W, Kucinska M, Pospieszna J, Dams-Kozlowska H, Chatuphonprasert W, Murias M. Antioxidant enzymes in cancer cells: their role in photodynamic therapy resistance and potential as targets for improved treatment outcomes. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063164.","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"3351_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"key":"3351_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9706792","author":"X Li","year":"2019","unstructured":"Li X, Chen Y, Zhao J, Shi J, Wang M, Qiu S, et al. The specific inhibition of SOD1 selectively promotes apoptosis of cancer cells via regulation of the ROS signaling network. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/9706792.","journal-title":"Oxid Med Cell Longev"},{"issue":"16","key":"3351_CR80","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/cmdc.202000160","volume":"15","author":"S Behnisch-Cornwell","year":"2020","unstructured":"Behnisch-Cornwell S, Bandaru SSM, Napierkowski M, Wolff L, Zubair M, Urbainsky C, Lillig C, Schulzke C, Bednarski PJ. Pentathiepins: A Novel Class of Glutathione Peroxidase 1 Inhibitors that Induce Oxidative Stress, Loss of Mitochondrial Membrane Potential and Apoptosis in Human Cancer Cells. ChemMedChem. 2020;15(16):1515\u201328.","journal-title":"ChemMedChem"},{"issue":"7679","key":"3351_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551(7679):247\u201350.","journal-title":"Nature"},{"issue":"5","key":"3351_CR82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.urolonc.2011.04.009","volume":"31","author":"J Lin","year":"2013","unstructured":"Lin J, Zahurak M, Beer TM, Ryan CJ, Wilding G, Mathew P, Morris M, Callahan JA, Gordon G, Reich SD, Carducci MA, Antonarakis ES. A non-comparative randomized phase II study of 2 doses of ATN-224, a copper\/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naive prostate cancer. Urol Oncol. 2013;31(5):581\u20138.","journal-title":"Urol Oncol"},{"issue":"7755","key":"3351_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270\u20134.","journal-title":"Nature"},{"key":"3351_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003430","author":"R Demuynck","year":"2021","unstructured":"Demuynck R, Efimova I, Naessens F, Krysko DV. Immunogenic ferroptosis and where to find it? J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2021-003430.","journal-title":"J Immunother Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03351-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03351-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03351-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:03:20Z","timestamp":1788930200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03351-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["3351"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03351-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"241"}}